home / stock / vaxx / vaxx short
Short Information | Vaxxinity Inc. (NASDAQ:VAXX)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 14,746,333 |
Total Actual Volume | 111,201,317 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 737,317 |
Average Short Percentage | 15.65% |
Is there a VAXX Short Squeeze or Breakout about to happen?
See the VAXX Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
05-08-2024 | $0.122 | $0.1111 | $0.1243 | $0.1093 | 2,884,425 | 573,462 | 19.88% |
05-07-2024 | $0.1288 | $0.1311 | $0.1336 | $0.1232 | 1,802,208 | 247,646 | 13.74% |
05-06-2024 | $0.1294 | $0.13 | $0.1349 | $0.1225 | 5,131,621 | 552,668 | 10.77% |
05-03-2024 | $0.1486 | $0.1411 | $0.1488 | $0.1222 | 56,880,076 | 7,477,267 | 13.15% |
05-02-2024 | $0.1151 | $0.1042 | $0.1182 | $0.1 | 12,042,281 | 666,666 | 5.54% |
05-01-2024 | $0.126 | $0.1146 | $0.1283 | $0.1067 | 2,377,488 | 299,000 | 12.58% |
04-30-2024 | $0.155 | $0.1227 | $0.16 | $0.1213 | 2,276,349 | 409,193 | 17.98% |
04-29-2024 | $0.1206 | $0.1535 | $0.1798 | $0.11 | 6,225,541 | 1,529,419 | 24.57% |
04-26-2024 | $0.121 | $0.1166 | $0.125 | $0.1075 | 1,999,747 | 263,400 | 13.17% |
04-25-2024 | $0.1351 | $0.1214 | $0.14 | $0.1175 | 2,937,959 | 371,309 | 12.64% |
04-24-2024 | $0.197 | $0.1326 | $0.1981 | $0.1266 | 4,556,116 | 608,369 | 13.35% |
04-23-2024 | $0.2454 | $0.2 | $0.2535 | $0.197 | 2,046,500 | 397,702 | 19.43% |
04-22-2024 | $0.2067 | $0.2696 | $0.2875 | $0.19 | 5,859,924 | 711,296 | 12.14% |
04-19-2024 | $0.48 | $0.4761 | $0.4818 | $0.414 | 820,065 | 59,075 | 7.2% |
04-18-2024 | $0.4216 | $0.4648 | $0.5 | $0.42 | 435,874 | 138,656 | 31.81% |
04-17-2024 | $0.459 | $0.418 | $0.46 | $0.4036 | 316,689 | 79,249 | 25.02% |
04-16-2024 | $0.49 | $0.4398 | $0.499 | $0.3911 | 440,797 | 66,594 | 15.11% |
04-15-2024 | $0.49 | $0.4461 | $0.538 | $0.4361 | 451,693 | 87,321 | 19.33% |
04-12-2024 | $0.54 | $0.4872 | $0.55 | $0.4817 | 460,355 | 65,364 | 14.2% |
04-11-2024 | $0.627 | $0.528 | $0.635 | $0.52 | 1,255,609 | 142,677 | 11.36% |
News, Short Squeeze, Breakout and More Instantly...
UB-312 is the first Parkinson's candidate to reduce pathology as measured by a seed amplification assay, and suggest clinical improvement on motor experiences of daily living. Data demonstrates target engagement and immunogenicity of the active immunotherapy UB-312 targeting pathological ...
BowFlex Inc. (BFXXQ) is expected to report for Q4 2024 Leafbuyer Technologies Inc (LBUY) is expected to report for Q3 2024 Pacific Booker Minerals Inc (PBMLF) is expected to report for Q1 2025 BZAM Ltd Com (BZAMF) is expected to report for Q1 2024 MJ Holdings Inc (MJNE) is expecte...
Orbital Infrastructure Group Inc. (OIGBQ) is expected to report for Q1 2024 OFS Credit Company Inc. (OCCI) is expected to report for Q2 2024 KBC Groupe NV ADR (KBCSY) is expected to report for Q1 2024 Daikin Industries Ltd ADR (DKILY) is expected to report $0.11 for Q4 2024 Invita...